This is getting the accelerated approval chances as clost to 100% as you humanly can.

$AVXL Kun Jin hire is the best indication we're going full bore for alz approval ASAP.

He said Anavex could do that also and all of that makes Anavex pleased how easy the FDA wants to make Accelerated approval here.

Anavex can still rise .. Blarcamesine will likely get approval around the world 🌎

So the current price level is so cheap and has so little downside that even with concerns about data and approval, the stock can rise 5x from here.

That's all perfect it's everything needed for full approval!

Well it was bound for an approval because the bar is low and aggregate economic benefit would far outweigh the aggregate economic burden from funerals cost Bullish for $AVXL $BIVI

look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

I think this bodes well for A2-73 getting AA and approval, being it is much safer and with better efficacy, it appears AA is coming to A2-73,

$CDTX FDA decision will be made tomorrow $SAVA, $MDGL & $RETA boys I can easily see this up 200%-300% in my opinion on an approval.

$SAVA I'm loving the move, can't wait for the approval, buy out at $500, sell at $1200.

$SAVA diseases like Alzheimer’s will have more Than 1 drug approved for the indication.. being first is great,

$SAVA FDA approved Biogen's AD drug is bullish for SAVA.

$SAVA biib up 3.00 on approval sava will go up 100+ on approval

no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !

This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.

This share price is a steal with those great Levo results this morning, and their other 3 approved and growing products.

Simufilam boosts soluble level of Amyloid bera42 which in turn improves or maintains cognition in Alz patients This, along with its superior safety profile, will win the approval undoubtedly!

Same exact ind approval news as maybe we see a repeat here even 100% run would be awesome.

Potential 100% or more upside due to soonest low float thanks to reverse stock split approved last 04 october 2022 and massive short from hedge fund thinking to obtain 110 mil cashless warrants!